Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Extrapolating Antifungal Animal Data to Humans - Is it reliable?

Stevens VM, Mueller SW, Reynolds PM, MacLaren R, Kiser TH.

Curr Fungal Infect Rep. 2020 Mar;14(1):50-62. doi: 10.1007/s12281-020-00370-x. Epub 2020 Jan 16.

PMID:
32201545
2.

Predicting gene expression using morphological cell responses to nanotopography.

Cutiongco MFA, Jensen BS, Reynolds PM, Gadegaard N.

Nat Commun. 2020 Mar 13;11(1):1384. doi: 10.1038/s41467-020-15114-1.

3.

Establishing the Therapeutic Index of Fluid Resuscitation in the Septic Patient: A Narrative Review and Meta-Analysis.

Reynolds PM, Wells L, MacLaren R, Scoular SK.

Pharmacotherapy. 2020 Mar;40(3):256-269. doi: 10.1002/phar.2371. Epub 2020 Feb 18. Review.

PMID:
31970818
4.

Coagulation Factor Xa (Recombinant), Inactivated-Zhzo (Andexanet Alfa) Hemostatic Outcomes and Thrombotic Event Incidence at an Academic Medical Center.

Stevens VM, Trujillo T, Mueller SW, MacLaren R, Reynolds PM, Kiser TH.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619896619. doi: 10.1177/1076029619896619.

5.

Customizable, engineered substrates for rapid screening of cellular cues.

Huethorst E, Cutiongco MF, Campbell FA, Saeed A, Love R, Reynolds PM, Dalby MJ, Gadegaard N.

Biofabrication. 2020 Feb 7;12(2):025009. doi: 10.1088/1758-5090/ab5d3f.

PMID:
31783378
6.

Assessment of Opioid Cross-reactivity and Provider Perceptions in Hospitalized Patients With Reported Opioid Allergies.

Powell MZ, Mueller SW, Reynolds PM.

Ann Pharmacother. 2019 Nov;53(11):1117-1123. doi: 10.1177/1060028019860521. Epub 2019 Jun 28.

PMID:
31253049
7.
8.

Impact of Macrolide Antibiotics on Hospital Readmissions and Other Clinically Important Outcomes in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Propensity Score-Matched Cohort Study.

Kiser TH, Reynolds PM, Moss M, Burnham EL, Ho PM, Vandivier RW; Colorado Pulmonary Outcomes Research Group (CPOR).

Pharmacotherapy. 2019 Mar;39(3):242-252. doi: 10.1002/phar.2221.

9.

Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill Patient.

Reynolds PM, Van Matre ET, Wright GC, McQueen RB, Burnham EL, Ho PJM, Moss M, Vandivier RW, Kiser TH; Colorado Pulmonary Outcomes Research Group (CPOR).

Pharmacotherapy. 2019 Mar;39(3):232-241. doi: 10.1002/phar.2212. Epub 2019 Jan 21.

PMID:
30592541
10.

Controlling fluid flow to improve cell seeding uniformity.

Reynolds PM, Holzmann Rasmussen C, Hansson M, Dufva M, Riehle MO, Gadegaard N.

PLoS One. 2018 Nov 15;13(11):e0207211. doi: 10.1371/journal.pone.0207211. eCollection 2018.

11.

Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.

Van Matre ET, Reynolds PM, MacLaren R, Mueller SW, Wright GC, Moss M, Burnham EL, Ho PM, Vandivier RW, Kiser TH.

J Thromb Haemost. 2018 Dec;16(12):2492-2500. doi: 10.1111/jth.14317. Epub 2018 Nov 15.

PMID:
30347498
12.

Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.

Reynolds PM, MacLaren R.

Pharmacotherapy. 2019 Mar;39(3):408-420. doi: 10.1002/phar.2172. Epub 2018 Sep 6.

PMID:
30101529
13.

Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose.

Little K, Lin CM, Reynolds PM.

Am J Case Rep. 2018 May 25;19:604-607. doi: 10.12659/AJCR.909063.

14.

Air as contrast media for hip arthrogram.

Awad A, Reynolds PM, Ashworth M.

Ann R Coll Surg Engl. 2017 Nov;99(8):662. doi: 10.1308/rcsann.2017.0061. Epub 2017 Sep 13. No abstract available.

15.

Image based Machine Learning for identification of macrophage subsets.

Rostam HM, Reynolds PM, Alexander MR, Gadegaard N, Ghaemmaghami AM.

Sci Rep. 2017 Jun 14;7(1):3521. doi: 10.1038/s41598-017-03780-z.

16.

Enhanced Human-Induced Pluripotent Stem Cell Derived Cardiomyocyte Maturation Using a Dual Microgradient Substrate.

Huethorst E, Hortigon M, Zamora-Rodriguez V, Reynolds PM, Burton F, Smith G, Gadegaard N.

ACS Biomater Sci Eng. 2016 Dec 12;2(12):2231-2239. Epub 2016 Oct 17.

17.

Injection Molding Micro- and Nanostructures in Thermoplastic Elastomers.

Stormonth-Darling JM, Saeed A, Reynolds PM, Gadegaard N.

Macromol Mater Eng. 2016 Aug;301(8):964-971. doi: 10.1002/mame.201600011. Epub 2016 May 6.

18.

Protein Adsorption as a Key Mediator in the Nanotopographical Control of Cell Behavior.

Ngandu Mpoyi E, Cantini M, Reynolds PM, Gadegaard N, Dalby MJ, Salmerón-Sánchez M.

ACS Nano. 2016 Jul 26;10(7):6638-47. doi: 10.1021/acsnano.6b01649. Epub 2016 Jul 15.

19.

Use of a Cholestyramine Washout in a Patient With Septic Shock on Leflunomide Therapy: A Case Report and Review of the Literature.

Laub M, Fraser R, Kurche J, Lara A, Kiser TH, Reynolds PM.

J Intensive Care Med. 2016 Jul;31(6):412-4. doi: 10.1177/0885066615610108. Epub 2015 Oct 6. Review.

PMID:
26446104
20.

A comparison of dexmedetomidine and placebo on the plasma concentrations of NGF, BDNF, GDNF, and epinephrine during severe alcohol withdrawal.

Reynolds PM, Mueller SW, MacLaren R.

Alcohol. 2015 Feb;49(1):15-9. doi: 10.1016/j.alcohol.2014.11.006. Epub 2015 Jan 22.

PMID:
25638740
21.

Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.

MacLaren R, Reynolds PM, Allen RR.

JAMA Intern Med. 2014 Apr;174(4):564-74. doi: 10.1001/jamainternmed.2013.14673.

PMID:
24535015
22.

Management of extravasation injuries: a focused evaluation of noncytotoxic medications.

Reynolds PM, MacLaren R, Mueller SW, Fish DN, Kiser TH.

Pharmacotherapy. 2014 Jun;34(6):617-32. doi: 10.1002/phar.1396. Epub 2014 Jan 13. Review.

PMID:
24420913
23.

Label-free segmentation of Co-cultured cells on a nanotopographical gradient.

Reynolds PM, Pedersen RH, Stormonth-Darling J, Dalby MJ, Riehle MO, Gadegaard N.

Nano Lett. 2013 Feb 13;13(2):570-6. doi: 10.1021/nl304097p. Epub 2013 Jan 2.

24.

Using nanotopography and metabolomics to identify biochemical effectors of multipotency.

Tsimbouri PM, McMurray RJ, Burgess KV, Alakpa EV, Reynolds PM, Murawski K, Kingham E, Oreffo RO, Gadegaard N, Dalby MJ.

ACS Nano. 2012 Nov 27;6(11):10239-49. doi: 10.1021/nn304046m. Epub 2012 Oct 24.

PMID:
23072705
25.

A dual gradient assay for the parametric analysis of cell-surface interactions.

Reynolds PM, Pedersen RH, Riehle MO, Gadegaard N.

Small. 2012 Aug 20;8(16):2541-7. doi: 10.1002/smll.201200235. Epub 2012 Jun 8.

PMID:
22678878
26.

Canine exposure to herbicide-treated lawns and urinary excretion of 2,4-dichlorophenoxyacetic acid.

Reynolds PM, Reif JS, Ramsdell HS, Tessari JD.

Cancer Epidemiol Biomarkers Prev. 1994 Apr-May;3(3):233-7.

27.

The effect of topical treatment by timolol versus pilocarpine on visual field progression in chronic simple glaucoma.

Crick RP, Vogel R, Reynolds PM, Ophth MC, Mills KB, Sass W.

J Glaucoma. 1993;2 Suppl A:12-4.

PMID:
19920462
28.

Effect of timolol versus pilocarpine on visual field progression in patients with primary open-angle glaucoma.

Vogel R, Crick RP, Mills KB, Reynolds PM, Sass W, Clineschmidt CM, Tipping R.

Ophthalmology. 1992 Oct;99(10):1505-11.

PMID:
1454315
29.

Non-seminomatous germ cell testicular tumours: residual masses after chemotherapy.

Levitt MD, Reynolds PM, Sheiner HJ, Byrne MJ.

Br J Surg. 1985 Jan;72(1):19-22.

PMID:
2578300
30.

Mitolactol chemotherapy for malignant melanoma: a phase II study.

Malden LT, Coates AS, Milton GW, McCarthy WH, Levi JA, Woods RL, Byrne MJ, Reynolds PM, Fox RM, Hedley DW, et al.

Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1045-6.

PMID:
6744338
31.

The assessment of response to therapy of bone metastases in breast cancer.

Rossleigh MA, Lovegrove FT, Reynolds PM, Byrne MJ, Whitney BP.

Aust N Z J Med. 1984 Feb;14(1):19-22.

PMID:
6235799
32.

Possible infectious etiology of six cases of Ewing's sarcoma in Western Australia.

Holman CD, Reynolds PM, Byrne MJ, Trotter JM, Armstrong BK.

Cancer. 1983 Nov 15;52(10):1974-6.

PMID:
6627212
33.

Adjuvant immunotherapy with BCG in stage II malignant melanoma.

Byrne MJ, Van Hazel G, Reynolds PM, Lemish WM, Holman CD.

J Surg Oncol. 1983 Jun;23(2):114-6.

PMID:
6343725
34.

Serial bone scans in the assessment of response to therapy in advanced breast carcinoma.

Rossleigh MA, Lovegrove FT, Reynolds PM, Byrne MJ.

Clin Nucl Med. 1982 Sep;7(9):397-402.

PMID:
7116728
35.
36.

Broncho-pleural fistula complicating rheumatoid lung disease.

Sharma SS, Reynolds PM.

Postgrad Med J. 1982 Mar;58(677):187-9. No abstract available.

37.

Clozic (ICI 55,897) in rheumatoid arthritis--a controlled comparison with gold.

Reynolds PM, McLeod MM, Dick WC.

Br J Clin Pract. 1981 Sep;35(9):306-8. No abstract available.

PMID:
6798986
38.

Cancer and communication: information-giving in an oncology clinic.

Reynolds PM, Sanson-Fisher RW, Poole AD, Harker J, Byrne MJ.

Br Med J (Clin Res Ed). 1981 May 2;282(6274):1449-51. No abstract available.

39.

Effect of oral zinc sulphate and penicillamine on zinc metabolism in patients with rheumatoid arthritis.

Kennedy AC, Bessent RG, Reynolds PM.

J Rheumatol. 1980 Sep-Oct;7(5):639-44.

PMID:
7441655
40.

Immunological status may predict clinical outcome in BCG treated melanoma.

Reynolds PM, Grimsley G, Dawkins RL, Byrne MJ, Zilko PJ.

Aust N Z J Med. 1980 Feb;10(1):39-43.

PMID:
6966494
41.

The estimation of whole-body zinc and Zn turnover in rheumatoid and osteoarthritis using 65Zn tracer.

Kennedy AC, Bessent RG, Davis P, Reynolds PM.

Br J Nutr. 1978 Jul;40(1):115-23.

PMID:
666994
42.

Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis.

El-Ghobarey AF, Mavrikakis ME, Macleod M, Reynolds PM, Capell HA, Spencer DG, Balint G, Mathieu JP, McAllister T, Cooney A, Dick WC.

Q J Med. 1978 Jul;47(187):385-400.

PMID:
102008
43.

Systems for early diagnosis and monitoring of glaucoma.

Crick RP, Reynolds PM.

Ann Ophthalmol. 1977 Sep;9(9):1158. No abstract available.

PMID:
900734
44.

The treatment of malignant pericardial effusion in carcinoma of the breast.

Reynolds PM, Byrne MJ.

Aust N Z J Med. 1977 Apr;7(2):169-71.

PMID:
268175
45.

Comparison of sulindac and aspirin in rheumatoid arthritis.

Reynolds PM, Rhymer AR, MacLeod MM, Buchanan WW.

Curr Med Res Opin. 1977;4(7):485-91.

PMID:
321183
46.

Thrombotic thrombocytopenic purpura--remission following splenectomy. Report of a case and review of the literature.

Reynolds PM, Jackson JM, Brine JA, Vivian AB.

Am J Med. 1976 Sep;61(3):439-47.

PMID:
986764
47.

Measurement of spinal mobility: a comparison of three methods.

Reynolds PM.

Rheumatol Rehabil. 1975 Aug;14(3):180-5.

PMID:
1162237
48.

A double-blind cross-over trial of Prenazone (DA 2370) and phenylbutazone in rheumatoid arthritis.

Reynolds PM, Sturrock RD, Isaacs A, Hart FD.

Rheumatol Rehabil. 1975 May;14(2):67-70.

PMID:
1096276
49.

Letter: Inquiry among rheumatism unit outpatients.

Hart FD, Wojtulewski JA, Reynolds PM.

Br Med J. 1975 Mar 8;1(5957):570. No abstract available.

50.

A single-blind crossover comparison of fenoprofen, ibuprofen and naproxen in rheumatoid arthritis.

Reynolds PM, Whorwell PJ.

Curr Med Res Opin. 1974;2(8):461-4. No abstract available.

PMID:
4614951

Supplemental Content

Loading ...
Support Center